IN-EyE


Ensayo clínico en fase IV, abierto, aleatorizado, de 3 brazos, multicéntrico y de 12 meses de duración, para evaluar la eficacia y seguridad de dos regímenes de tratamiento, bimensual o PRN flexible individualizado de "tratar y extender". versus un régimen PRN según criterios de estabilización mediante evaluaciones mensuales de inyecciones intravítreas de ranibizumab 0,5 mg en pacientes naive con neovascularización coroidea secundaria a la degeneración macular relacionada con la edad.

This window will launch a new working window that will let you log into the study. If that window doesn't appear, maybe your browser has some pop-up killer software installed on it. (This kind of software was designed to stop unwanted emerging windows ads as you surf the internet.)

The links below contain information on how to disable two of the most popular pop-up killers: Google and Yahoo toolbars. If you have installed a different pop-up killer, please follow the uninstall instructions provided by your software provider.


If you have any problem or question regarding the e-CRF, please contact support@clindemiurg.com

PRIVACY

Copyright Demiurg Clinical Technologies, SLL 2009
Sitio web diseñado para Microsoft Internet Explorer 6 y superiores